FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028547579> ?p ?o ?g. }

• W2028547579 endingPage "885" @default.
• W2028547579 startingPage "876" @default.
• W2028547579 abstract "Oxaliplatin, classical [5-fluorouracil (5-FU)] and non-classical (AG337) thymidylate synthase inhibitors have shown promising activity in the treatment of cancer. This study investigates the cytotoxic effects of oxaliplatin in combination with 5-FU and AG337 in cultured human colon (HT29, CaCo2), breast (MCF-7, MDA-MB-231) and ovarian (2008) cancer cell lines, and their derived counterparts selected for their resistance to 5-FU (HT29-5-FU), doxorubicin (MCF-7mdr) or cisplatin (2008C13). Therapeutic experiments were conducted in mice bearing colon-HT29 xenografts and in the GR hormone-independent mammary carcinoma model. In vitro, oxaliplatin shows potent cytotoxic activity in colon (IC50 from 2.1 +1.1 to 5.9 ± 1.7 µM), ovarian (IC50=10 ± 1.6 µM) and breast cancer cells (IC50 from 7.4+2.7 to 17.9 +7.1µM). Oxaliplatin was a potent inhibitor of DNA synthesis and bound to cellular DNA. Surprisingly, the overall amount of oxaliplatin DNA binding was significantly inferior to that induced by isocytotoxic concentrations of cisplatin in HT29 (p=0.026). In vitro, synergistic antiproliferative effects were observed when oxaliplatin was added to 5-FU and AG337. Those synergistic effects of combinations were maintained in colon HT29-5-FU cancer cells. In vivo, 5-FU increased significantly the antitumor activity of oxaliplatin in HT29 xenografts (p=0.0036), and similarly 5-FU and AG337 increased the activity of oxaliplatin in the GR tumor model (p=0.0012). These data may encourage further clinical investigation of oxaliplatin in combination with classical and non-classical thymidylate synthase inhibitors in the treatment of human cancers." @default.
• W2028547579 created "2016-06-24" @default.
• W2028547579 creator A5005930649 @default.
• W2028547579 creator A5013952219 @default.
• W2028547579 creator A5052850973 @default.
• W2028547579 creator A5055631929 @default.
• W2028547579 creator A5067410992 @default.
• W2028547579 creator A5075172084 @default.
• W2028547579 creator A5080003606 @default.
• W2028547579 creator A5090983937 @default.
• W2028547579 date "1997-10-01" @default.
• W2028547579 modified "2023-10-16" @default.
• W2028547579 title "Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers" @default.
• W2028547579 doi "https://doi.org/10.1097/00001813-199710000-00009" @default.
• W2028547579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9402315" @default.
• W2028547579 hasPublicationYear "1997" @default.
• W2028547579 type Work @default.
• W2028547579 sameAs 2028547579 @default.
• W2028547579 citedByCount "219" @default.
• W2028547579 countsByYear W20285475792012 @default.
• W2028547579 countsByYear W20285475792013 @default.
• W2028547579 countsByYear W20285475792014 @default.
• W2028547579 countsByYear W20285475792015 @default.
• W2028547579 countsByYear W20285475792016 @default.
• W2028547579 countsByYear W20285475792018 @default.
• W2028547579 countsByYear W20285475792019 @default.
• W2028547579 countsByYear W20285475792020 @default.
• W2028547579 countsByYear W20285475792021 @default.
• W2028547579 countsByYear W20285475792022 @default.
• W2028547579 countsByYear W20285475792023 @default.
• W2028547579 crossrefType "journal-article" @default.
• W2028547579 hasAuthorship W2028547579A5005930649 @default.
• W2028547579 hasAuthorship W2028547579A5013952219 @default.
• W2028547579 hasAuthorship W2028547579A5052850973 @default.
• W2028547579 hasAuthorship W2028547579A5055631929 @default.
• W2028547579 hasAuthorship W2028547579A5067410992 @default.
• W2028547579 hasAuthorship W2028547579A5075172084 @default.
• W2028547579 hasAuthorship W2028547579A5080003606 @default.
• W2028547579 hasAuthorship W2028547579A5090983937 @default.
• W2028547579 hasConcept C121608353 @default.
• W2028547579 hasConcept C123321153 @default.
• W2028547579 hasConcept C126322002 @default.
• W2028547579 hasConcept C150903083 @default.
• W2028547579 hasConcept C185592680 @default.
• W2028547579 hasConcept C202751555 @default.
• W2028547579 hasConcept C207001950 @default.
• W2028547579 hasConcept C2776694085 @default.
• W2028547579 hasConcept C2777752497 @default.
• W2028547579 hasConcept C2778239845 @default.
• W2028547579 hasConcept C2780427987 @default.
• W2028547579 hasConcept C2780456651 @default.
• W2028547579 hasConcept C2780962732 @default.
• W2028547579 hasConcept C2781303535 @default.
• W2028547579 hasConcept C502942594 @default.
• W2028547579 hasConcept C526805850 @default.
• W2028547579 hasConcept C55493867 @default.
• W2028547579 hasConcept C71924100 @default.
• W2028547579 hasConcept C86803240 @default.
• W2028547579 hasConcept C98274493 @default.
• W2028547579 hasConceptScore W2028547579C121608353 @default.
• W2028547579 hasConceptScore W2028547579C123321153 @default.
• W2028547579 hasConceptScore W2028547579C126322002 @default.
• W2028547579 hasConceptScore W2028547579C150903083 @default.
• W2028547579 hasConceptScore W2028547579C185592680 @default.
• W2028547579 hasConceptScore W2028547579C202751555 @default.
• W2028547579 hasConceptScore W2028547579C207001950 @default.
• W2028547579 hasConceptScore W2028547579C2776694085 @default.
• W2028547579 hasConceptScore W2028547579C2777752497 @default.
• W2028547579 hasConceptScore W2028547579C2778239845 @default.
• W2028547579 hasConceptScore W2028547579C2780427987 @default.
• W2028547579 hasConceptScore W2028547579C2780456651 @default.
• W2028547579 hasConceptScore W2028547579C2780962732 @default.
• W2028547579 hasConceptScore W2028547579C2781303535 @default.
• W2028547579 hasConceptScore W2028547579C502942594 @default.
• W2028547579 hasConceptScore W2028547579C526805850 @default.
• W2028547579 hasConceptScore W2028547579C55493867 @default.
• W2028547579 hasConceptScore W2028547579C71924100 @default.
• W2028547579 hasConceptScore W2028547579C86803240 @default.
• W2028547579 hasConceptScore W2028547579C98274493 @default.
• W2028547579 hasIssue "9" @default.
• W2028547579 hasLocation W20285475791 @default.
• W2028547579 hasLocation W20285475792 @default.
• W2028547579 hasOpenAccess W2028547579 @default.
• W2028547579 hasPrimaryLocation W20285475791 @default.
• W2028547579 hasRelatedWork W1584164555 @default.
• W2028547579 hasRelatedWork W2078157652 @default.
• W2028547579 hasRelatedWork W2082615672 @default.
• W2028547579 hasRelatedWork W2089918500 @default.
• W2028547579 hasRelatedWork W2348071463 @default.
• W2028547579 hasRelatedWork W2349697926 @default.
• W2028547579 hasRelatedWork W2358719358 @default.
• W2028547579 hasRelatedWork W2364358549 @default.
• W2028547579 hasRelatedWork W2903876151 @default.
• W2028547579 hasRelatedWork W595487296 @default.
• W2028547579 hasVolume "8" @default.
• W2028547579 isParatext "false" @default.
• W2028547579 isRetracted "false" @default.
• W2028547579 magId "2028547579" @default.

• next